HPC
PFE icon

Hobart Private Capital’s Pfizer PFE Stock Holding History

Hobart Private Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,877
Closed -$269K – 121
2021
Q2 		$269K Sell
6,877
-696
-9% -$27.1K 0.11% 108
2021
Q1 		$274K Sell
7,573
-4,544
-38% -$161K 0.11% 112
2020
Q4 		$446K Sell
12,117
-5,704
-32% -$209K 0.2% 93
2020
Q3 		$621K Sell
17,821
-16,037
-47% -$562K 0.32% 56
2020
Q2 		$1.05M Sell
33,858
-14,282
-30% -$485K 0.59% 36
2020
Q1 		$1.49M Sell
48,140
-6,788
-12% -$231K 1.02% 23
2019
Q4 		$2.04M Buy
54,928
+25,873
+89% +$922K 1.25% 18
2019
Q3 		$990K Buy
29,055
+17,574
+153% +$639K 0.68% 43
2019
Q2 		$472K Buy
11,481
+4,795
+72% +$190K 0.33% 66
2019
Q1 		$269K Sell
6,686
-1,202
-15% -$48.1K 0.2% 123
2018
Q4 		$327K Sell
7,888
-13,990
-64% -$581K 0.28% 85
2018
Q3 		$915K Sell
21,878
-1,385
-6% -$53.3K 0.7% 46
2018
Q2 		$801K Buy
23,263
+11,419
+96% +$390K 0.65% 52
2018
Q1 		$399K Buy
+11,844
New +$407K 0.35% 81

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hobart Private Capital's PFE Position: Q3 2021 in Review

Hobart Private Capital sold out of Pfizer (PFE) in Q3 2021, closing a stake of 6,877 shares — an estimated $269K sold.

Hobart Private Capital first reported a position in PFE in Q1 2018 and held it in 14 quarters. The position peaked at $2.04M in Q4 2019. 2,805 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Hobart Private Capital reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
  • Hobart Private Capital sold 6,877 Pfizer shares in Q3 2021, an estimated $269K.
  • Hobart Private Capital first reported a position in Pfizer in Q1 2018 and held it in 14 quarters.
  • Hobart Private Capital's Pfizer position peaked at $2.04M in Q4 2019.
  • 2,805 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Hobart Private Capital's 13F filing for Q3 2021, filed 11 Mar 2024.